The influence of remifentanil to renal functions in perioperative patients with chronic kidney disease(prospective study)

The influence of remifentanil to renal functions in perioperative patients with chronic kidney disease(prospective study) - The influence of remifentanil to renal functions in perioperative patients with chronic kidney disease(prospective study)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011297

Enrollment

Registered

2013-07-27

Start date

2013-07-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative adult patients with chronic kidney disease undergoing orthopedic surgery

Interventions

Using remifentanil Not using remifentanil

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Perioperative adult patients with CKD (CKD GFR stage 3: 30 =< eGFRcreat < 60) undergoing posterior spinal decompression (except instrumentation)

Exclusion criteria

Exclusion criteria: Patients with heart failure, severe valvular disease, not sinus rhythm and obesity(BMI >= 30)

Design outcomes

Primary

Measure	Time frame
estimated glomerular filtration rate	—

Countries

Japan

Contacts

Public ContactTakerou Terashi

Kagoshima Red Cross Hospital Department of anesthesiology

terashi@m2.kufm.kagoshima-u.ac.jp099-261-2111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026